HOME
ABOUT IAC
CONTACT
A-Z INDEX
DONATE
SHOP
SUBSCRIBE
Immunization Action Coalition
IAC Home
|
Technically Speaking
|
September 2014
Technically Speaking
Monthly Column by Deborah Wexler, MD
Deborah Wexler MD
Technically Speaking is a monthly column written by IAC’s Executive Director Deborah Wexler, MD. The column is featured in The Children's Hospital of Philadelphia Vaccine Education Center’s (VEC's) monthly e-newsletter for healthcare professionals. Technically Speaking columns cover practical topics in immunization delivery such as needle length, vaccine administration, cold chain, and immunization schedules.
Check out a recent issue of Vaccine Update for Healthcare Providers. The VEC e-newsletter keeps providers up to date on vaccine-related issues and includes reviews of recently published journal articles, media recaps, announcements about new resources, and a regularly updated calendar of events.
TECHNICALLY SPEAKING
What's New in the 2014–15 CDC Influenza Vaccine Recommendations
Published September 2014
Information presented in this article may have changed since the original publication date. For the most current immunization recommendations from the Advisory Committee on Immunization Practices, visit www.immunize.org/acip/acip_vax.asp.
The Centers for Disease Control and Prevention’s (CDC) annual update on the use of influenza vaccine, Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP) — United States, 2014–15 Influenza Season, was published in the August 15 issue of MMWR on pages 691-697.
All people age 6 months and older who do not have contraindications should receive influenza vaccination annually — a core ACIP recommendation since the 2010-11 influenza season. Healthcare providers should begin recommending and providing influenza vaccination as soon as vaccine is available and continue vaccinating as long as influenza viruses are circulating.
Changes in the 2014-15 ACIP recommendations
As in previous seasons, children age 6 months through 8 years need two doses of influenza vaccine during their first vaccination season in order to prime and optimize their immune response. ACIP recommends you use one of two possible approaches to determine the number of doses needed for the 2014–15 season. The first approach considers only doses of seasonal influenza vaccine received since July 1, 2010. The second approach may be used when a well-documented vaccination history from before the 2010–11 season is available. For details, see Figure 1 on page 695 of the ACIP recommendations or refer to the Immunization Action Coalition’s handout titled Guide for Determining the Number of Doses of Influenza Vaccine to Give to Children Age 6 Months Through 8 Years During the 2014–2015 Influenza Season. Children who need two doses should receive their first dose as soon as possible after vaccine becomes available, and the second dose ≥ 4 weeks later.
Based on ACIP's review of evidence indicating that the live attenuated influenza vaccine (LAIV, FluMist®, MedImmune) is more effective than inactivated influenza vaccine (IIV) against laboratory-confirmed influenza among younger children, the committee has stated a preference for the use of LAIV in healthy children age 2 through 8 years who have no contraindications or precautions to its use. Because both LAIV and injectable influenza vaccine (IIV) are effective in protecting children, the recommendation stresses that if LAIV is not immediately available, administer IIV. IIV should be used to ensure that opportunities to vaccinate and protect children are not missed or delayed.
For people with chronic conditions that might predispose them to a higher risk of influenza complications (e.g., chronic pulmonary, cardiovascular [except isolated hypertension], renal, hepatic, neurologic, hematologic, or metabolic disorders [including diabetes mellitus]), the use of LAIV should be considered a precaution. Previously, LAIV was contraindicated for these individuals.
For people with asthma who are age 5 years and older, the use of LAIV should be considered a precaution. Previously, LAIV was contraindicated for all people with asthma. LAIV continues to be contraindicated for children age 2 through 4 years who have asthma or who have had a medically documented or provider-described episode of wheezing within the past 12 months.
Taking influenza antiviral medications within the previous 48 hours was previously listed as a precaution to the use of LAIV; however, ACIP now lists it as a contraindication.
Be sure to consult the ACIP recommendations (pages 691-697) for complete details about influenza vaccine use including all contraindications and precautions.
If you have additional questions, be sure to check the following helpful influenza vaccine resources.
From CDC
Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP)—United States, 2014–15 Influenza Season on pages 691-697
CDC's Influenza web section
CDC's free resources related to influenza
From the Immunization Action Coalition
Influenza (IIV) Vaccine Information Statement (and available translations)
Influenza (LAIV) Vaccine Information Statement (and available translations)
Influenza Vaccine Products for the 2014–2015 Influenza Season
Screening Checklist for Contraindications to Inactivated Injectable Influenza Vaccination
Screening Checklist for Contraindications to Live Intranasal Attenuated Influenza Vaccination
Standing Orders for Administering Influenza Vaccine to Adults
Standing Orders for Administering Influenza Vaccines to Children and Adolescents
Guide for Determining the Number of Doses of Influenza Vaccine to give to children age 6 months through 8 years during the 2014–2015 influenza season
Influenza Vaccination of People with a History of Egg Allergy
Declination of Influenza Vaccination
Declination of Influenza Vaccination (Spanish)
From the Vaccine Education Center
Influenza: What you should know
Influenza: What you should know (Spanish)
2014 ISSUES >> view all
DECEMBER 2014
Use this Handy Checklist to Help Improve your Practice’s Vaccination Rates
NOVEMBER 2014
Know the "7 Rights"” of Vaccine Administration
OCTOBER 2014
CDC Issues New Pneumococcal Vaccine Recommendations for Adults Age 65 Years and Older
SEPTEMBER 2014
What's New in the 2014–15 CDC Influenza Vaccine Recommendations
AUGUST 2014
Make Sure You Choose the Proper Needle Length When Vaccinating Your Patients
JULY 2014
Protect Your Significant Investment in Vaccines So That They Can Protect Your Patients
JUNE 2014
Immunization Action Coalition Launches “Question of the Week” in its Free Weekly Newsletter
MAY 2014
Use These Resources to Help you Avoid Vaccine Administration Errors in Your Practice
APRIL 2014
Resources to Help Assure Competency of Clinic Staff Administering Vaccines
MARCH 2014
Simple Tips to Expedite Vaccination in Your Practice
FEBRUARY 2014
Newly Updated! CDC’s 2014 Immunization Schedules and IAC’s Easy-to-Use Summaries
JANUARY 2014
A Strong Provider Recommendation Matters. Don’t Just "Offer" HPV Vaccine to Parents for Preteens. Recommend It!
 
This page was updated on October 3, 2014
This page was reviewed on October 3, 2014
 
- Guide to immunize.org -
A-Z INDEX
ABOUT IAC
IAC in the News
Staff
IAC History through Film
ACIP
RECOMMENDATIONS
ADOLESCENT VACCINATION
ADULT VACCINATION
ADULT VACCINATION GUIDE
ASK THE EXPERTS
Administering Vaccines
COVID-19
COVID-19 & Routine Vac
Hepatitis B
MMR
Storage and Handling
>> view all
BECKY PAYNE AWARD
BILLING & CODING
BIRTH DOSE GUIDEBOOK
CALENDAR OF EVENTS
CDC INFORMATION
CDC SCHEDULES
CLINIC TOOLS
Administering Vaccines
Adolescent Vaccination
Adult Vaccination
Screening for Contraindications
Storage & Handling
Vaccination and COVID-19
Vaccine Recommendations
>> view all
COALITIONS FOR
IMMUNIZATION
CONTRIBUTE TO IAC
COVID-19 RELATED
Ask the Experts: COVID-19
Ask the Experts: COVID-19
   & Routine Vac
Clinic Tools: Vaccination and
   COVID-19
Repository of Resources
Vaccines: COVID-19
DEAR COLLEAGUE LETTERS
16-year-old Visit
HPV
MenACWY Dose #2
DONATE TO IAC
EDUCATIONAL MATERIALS
EMAIL NEWS SERVICES
E-NEWSLETTER: IAC EXPRESS
EXEMPTIONS
FAQs
FAVORITES
FDA PACKAGE INSERTS
FILMS ABOUT IAC
GIVE BIRTH TO THE
END OF HEP B
HANDOUTS FOR
PATIENTS & STAFF
View All Materials
Administering Vaccines
Adolescent Vaccination
Adult Vaccination
Contraindications / Precautions
Documenting Vaccination
Healthcare Personnel
Managing Vaccine Reactions
Parent Handouts
Pregnancy and Vaccines
Q&As: Diseases and Vaccines
Q&As: Easy-to-Read
Schedules for Patients
Screening Checklists
Standing Orders Templates
Storage & Handling
Strategies & Policies
Temperature Logs
Top Handouts
Vaccine Confidence
Vaccine Recommendations
>> view all
HEP B BIRTH DOSE
HONOR ROLLS
Hep B Birth Dose
Mandatory Flu Vaccination for HCP
MenB Vaccination for Colleges
IAC EXPRESS
Subscribe to IAC Express
IMAGE LIBRARY
LAWS AND MANDATES
MANUFACTURERS
MASS VACCINATION
RESOURCES
NATIONAL ADULT &
INFLUENZA
IMMUNIZATION SUMMIT
NEWS & INFORMATION
NEWSLETTER SIGN UP
OFFICIAL RELEASES
ACIP
CDC
FDA
PACKAGE INSERTS
PARTNERS
PHARMACISTS
PHOTOS
POWERPOINT SLIDE SETS
PREGNANCY AND
VACCINES
PRESS ROOM
PROTECT NEWBORNS
FROM HEP B
PUBLICATIONS
IAC Express
Vaccinating Adults:
   A Step-by-Step Guide
Hepatitis B What Hospitals
   Need to Do to
   Protect Newborns
Needle Tips Archive
Vaccinate Adults Archive
Vaccinate Women Archive
REGISTRIES
SCHOOL VACCINATION REQUIREMENTS
SHOP IAC
DVD Immunization Techniques
Laminated Schedules
Patient Record Cards
Flu Vaccine Buttons and Stickers
"Vaccines Save Lives" Pins
SITE MAP
SLIDE SETS
STANDING ORDERS
STATE INFORMATION
Immunization Websites
Laws and Mandates for School Entry
Immunization Program Managers
SUBSCRIBE TO IAC EXPRESS
SUPPORT IAC
TALKING ABOUT VACCINES
Adjuvants & Ingredients
Autism
Importance of Vaccination
MMR Vaccine
Religious Concerns
Vaccine Safety
>> view all
TECHNICALLY SPEAKING
(ARCHIVE)
TRANSLATIONS
IAC Handouts
VISs
TRAVEL (INTERNATIONAL)
UNPROTECTED PEOPLE
STORIES
Chickenpox
Hepatitis B
Measles
Whooping Cough
>> view all
VACCINATING ADULTS:
A STEP-BY-STEP GUIDE
VACCINE INFORMATION
STATEMENTS
Translations
VACCINE
MANUFACTURERS
VACCINE POLICY &
LICENSURE
ACIP
FDA
WHO
VACCINE SAFETY
VACCINE TIMELINE
VACCINES
COVID-19
Hepatitis B
HPV (Human papillomavirus)
Influenza
Pertussis
Varicella
>> view all
VIDEO OF THE WEEK
VIDEO LIBRARY
VISs
Translations
WHAT'S NEW OR UPDATED AT IAC
Handouts
VISs and Translations
Web Pages
 
Immunization Action Coalition  •  2550 University Avenue West  •  Suite 415 North  •  Saint Paul, Minnesota  •  55114
tel 651-647-9009  •  fax 651-647-9131
 
 
 
This website is supported in part by a cooperative agreement from the National Center for Immunization and Respiratory Diseases (Grant No. 1NH23IP922654) at the Centers for Disease Control and Prevention (CDC) in Atlanta, GA. The website content is the sole responsibility of IAC and does not necessarily represent the official views of CDC.